H.R. 8712

H.R. 8712: To amend the Securities Exchange Act of 1934 to require issuers to make certain disclosures relating to the Xinjiang Uyghur Autonomous Region, and for other purposes.

Introduced Suhas Subramanyam (D) HOUSE_BILL — 119th Congress
Plain English Summary

H.R. 8712 aims to amend the Securities Exchange Act of 1934 by requiring companies to disclose information related to their business operations in the Xinjiang Uyghur Autonomous Region of China. This includes any materials or products sourced from the region, which has been associated with human rights abuses against the Uyghur population. The bill seeks to increase transparency and hold companies accountable for their supply chains.

Positive Media Summary

Supporters of H.R. 8712 have praised the bill for promoting corporate accountability and human rights. Media coverage highlights the importance of transparency in supply chains, especially concerning regions known for human rights violations. Advocates argue that this legislation will encourage companies to take ethical considerations into account and can help consumers make informed choices.

Negative Media Summary

Critics of H.R. 8712 express concerns that the bill may impose excessive regulatory burdens on businesses, particularly those with complex global supply chains. Some media outlets argue that the legislation could lead to unintended economic consequences, including the potential for reduced trade with China and increased costs for consumers. Additionally, there are worries about the feasibility of accurately tracking and disclosing supply chain information.

Conflict of Interest Analysis Deep Analysis
3/10
Risk Level
Low
Total Donations
$0
PAC Percentage
0%
Policy Area
Finance and Financial Sector

The analysis of H.R. 8712, which focuses on disclosures related to the Xinjiang Uyghur Autonomous Region, reveals no direct industry overlaps between the sponsor Suhas Subramanyam's top donor industries and the subject matter of the bill. The lobbying activity in this policy area is primarily undisclosed, with the exception of DIRSHU INTERNATIONAL contributing $100,000. However, this contribution does not indicate a direct conflict since it is not tied to the specific industries involved in the bill's focus. The lack of direct financial ties or industry overlaps suggests that the risk of conflict of interest is low. Voters should be aware that while lobbying activity exists, the absence of disclosed financial interests related to the bill's subject matter minimizes potential conflicts.

Lobbying Activity — Who's Pushing?

Organizations that lobbied on issues related to this bill's policy area.

Client Lobbying Firm Amount
DIRSHU INTERNATIONAL MERKAVA STRATEGIES CORPORATION $100,000
CEO WORKS SAUNDERS GLOBAL DIPLOMACY $45,000
KAZI IG SAUNDERS GLOBAL DIPLOMACY $15,000
SOUTHERN FOLGER CONTRACTING BBT STRATEGIES LLC $10,000
WATERFRONT GLOBAL BBT STRATEGIES LLC $5,200
DIGITALEUROPE VIVID STRATEGIES LLC undisclosed
INTERNATIONAL CHRISTIAN CHAMBER OF COMMERCE MERKAVA STRATEGIES CORPORATION undisclosed
DR. STEPHEN SOLOWAY MERKAVA STRATEGIES CORPORATION undisclosed
ONE ISRAEL FUND MERKAVA STRATEGIES CORPORATION undisclosed
HEMOGLOBIN OXYGEN THERAPEUTICS MERKAVA STRATEGIES CORPORATION undisclosed
ATAOLLAH AMINPOUR MERKAVA STRATEGIES CORPORATION undisclosed
HERSEL NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MORAD BEN NEMAN MERKAVA STRATEGIES CORPORATION undisclosed
MARK SCOTT MERKAVA STRATEGIES CORPORATION undisclosed
BORIS MINTS MERKAVA STRATEGIES CORPORATION undisclosed

Source: Senate Lobbying Disclosure Act (LDA) filings, 2026

Sponsor's Top Donor Industries

Top industries funding Suhas Subramanyam, ranked by total contributions.

Health Professionals $40,000,000
Individuals: $40,000,000 PACs: $0
Retired $12,500,000
Individuals: $12,500,000 PACs: $0

Source: OpenSecrets.org (Center for Responsive Politics)

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us